SCM
GMED icon

Soleus Capital Management’s Globus Medical GMED Stock Holding History

Soleus Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37M Sell
468,922
-260,545
-36% -$22.1M 1.28% 21
2026
Q1 		$62.9M Sell
729,467
-157,533
-18% -$14.1M 2.55% 11
2025
Q4 		$77.4M Buy
887,000
+711,000
+404% +$54M 2.86% 9
2025
Q3 		$10.1M Buy
+176,000
New +$10.1M 0.51% 46
2024
Q3 		– Sell
-86,000
Closed -$5.89M – 93
2024
Q2 		$5.89M Buy
+86,000
New +$5.14M 0.52% 58

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Soleus Capital Management's GMED Position: Q2 2026 in Review

Soleus Capital Management reduced its Globus Medical (GMED) stake by 36% in Q2 2026, selling an estimated $22.1M and leaving 468,922 shares worth $37M. The position accounts for 1.28% of the portfolio, ranked #21.

Soleus Capital Management first reported a position in GMED in Q2 2024 and has held it in 5 quarters since. The position peaked at $77.4M in Q4 2025. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Soleus Capital Management held 468,922 shares of Globus Medical worth $37M as of Q2 2026.
  • Soleus Capital Management sold 260,545 Globus Medical shares in Q2 2026, an estimated $22.1M.
  • Globus Medical made up 1.28% of Soleus Capital Management's portfolio in Q2 2026, its #21 holding.
  • Soleus Capital Management first reported a position in Globus Medical in Q2 2024 and has held it in 5 quarters since.
  • Soleus Capital Management's Globus Medical position peaked at $77.4M in Q4 2025.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.